Bloomberg Deals 3/11/2026

Watch on YouTube ↗  |  March 11, 2026 at 19:31  |  46:29  |  Bloomberg Markets

Summary

  • The defense sector is experiencing a massive surge in M&A and IPO activity, driven by sustained geopolitical conflicts in Ukraine and the Middle East, with advisors reporting the busiest pipeline in 25 years.
  • The pharmaceutical industry is facing a massive "patent cliff" starting in 2026, with over $300 billion in global sales losing exclusivity, forcing large-cap pharma to aggressively acquire innovative biotech firms to replenish their pipelines.
  • Activist investor Starboard Value has taken a $350 million stake in CarMax, aiming to revamp its clunky digital interface to unlock the value of its massive physical footprint.
  • Starboard Value is also targeting Lamb Weston for aggressive cost-cutting and TripAdvisor for a sum-of-the-parts valuation unlock, arguing that the market is mispricing companies based on misunderstood AI disruption risks.
  • Corporate M&A is seeing strategic consolidation, highlighted by Cintas acquiring UniFirst for $5.5 billion to extract $375 million in synergies, and a private equity bid to take Papa John's private.
Trade Ideas
Aaron Kirchfeld Executive Editor, Bloomberg Deals 1:04
We're just seeing a huge surge in demand for these defense and defense tech companies. Owners... are out there aggressively selling defense assets or buying to build their war chest literally and figuratively for future demand. Ongoing geopolitical conflicts are creating a structural, long-term tailwind for government defense spending. This guarantees robust revenue pipelines for prime contractors and drives a massive wave of consolidation and premium buyouts for smaller defense tech firms. LONG. The sector offers a hedge against geopolitical volatility while benefiting from the strongest M&A and IPO pipeline seen in a quarter-century. A sudden, unexpected de-escalation in global conflicts could lead to defense budget cuts and a cooling of M&A premiums.
Nora Anchor/Reporter, Bloomberg 20:18
The shares of Papa John's are surging. A backed investment fund has submitted a bid to take Papa John's private. Private equity interest establishes a hard floor on the stock's valuation and highlights the underlying cash flow value of the franchise network. This initial bid puts the company in play, potentially triggering a bidding war or forcing management into shareholder-friendly restructuring. LONG. This is a classic event-driven M&A play offering immediate upside potential from a takeover premium. The private equity deal falls through, financing dries up, or the board rejects the bid without a backup plan, causing the stock to retrace its gains.
David Varley Reporter, Bloomberg 20:48
Cintas snapping up a uniform maker UniFirst in a $5.5 billion cash and stock acquisition... The companies have expected synergies coming from the deal of $375 million. This strategic acquisition removes a competitor and consolidates the uniform rental market. The massive $375 million in projected synergies will directly flow to the bottom line, giving the combined entity superior pricing power and operational efficiency. LONG. Consolidation in a steady, recurring-revenue industrial sector with a clear line-of-sight to significant cost savings creates long-term shareholder value. Antitrust regulators could block or delay the merger due to market overlap, or integration hurdles could delay the realization of the projected synergies.
Krishna Veeraraghavan Global Co-Head of M&A, Paul Weiss 23:04
You have the large pharmaceutical companies which have these patent cliffs coming off. They're going to lose exclusivity and they need to fill that pipeline... they have an exceeding amount of financial ability and capital to do that. Big Pharma is facing an existential revenue threat as blockbuster drugs lose patent protection. Armed with massive cash reserves, they will be forced to aggressively acquire small and mid-cap biotech companies—specifically in oncology, immunology, and cardiometabolic spaces—to buy innovation, driving up valuations across the entire biotech sector. LONG. A target-rich environment combined with desperate, cash-rich buyers will create significant buyout premiums for innovative biotech firms. Increased FTC antitrust scrutiny could chill mega-mergers, or high-profile clinical trial failures could reduce the pool of viable acquisition targets.
Jeff Smith CEO, Starboard Value 35:56
We're buying into CarMax at tangible book value... they have the benefit of the omni channel footprint... they need to fix the digital experience for the consumer... it's fairly easy to fix and takes some prioritization. CarMax possesses an irreplaceable physical asset base but has been penalized by the market for a clunky digital interface compared to digital-first peers. Activist pressure will force management to modernize the digital front-end, unlocking the full value of its omnichannel model and driving multiple expansion from its currently depressed valuation. LONG. Buying a market leader at tangible book value with a highly achievable, activist-driven operational catalyst provides a strong margin of safety and significant upside. Prolonged high interest rates or a macroeconomic recession severely depress consumer demand for used vehicles, offsetting operational improvements.
Jeff Smith CEO, Starboard Value 41:11
They've announced that they can reduce their overhead by about $250 million. We think they should be able to do twice as much, and we think they should look at their international operations and rationalize those. Lamb Weston operates in a stable, oligopolistic market (French fries) that is highly insulated from AI disruption. Starboard's involvement will force management to double their cost-cutting targets and optimize underperforming international segments, leading to rapid margin expansion. LONG. Acquiring a fundamentally stable business at a mid-single-digit multiple with a clear, activist-enforced roadmap for aggressive cost reduction presents an asymmetric risk/reward profile. Agricultural issues (potato crop failures), supply chain disruptions, or entrenched management resisting the activist's deeper cost-cutting demands.
Jeff Smith CEO, Starboard Value 42:16
We get to own this whole thing at like three or four times EBITDA... the growing assets of Viator and The Fork which are actually marketplace businesses are worth way more than three or four times. The broader market is heavily discounting TripAdvisor due to fears that AI will destroy its legacy review business. This fear completely masks the standalone value and rapid growth of its Viator and The Fork segments. Activist pressure will likely force a spin-off or restructuring to highlight and monetize these hidden gems. LONG. This is a sum-of-the-parts value play where the market's AI-driven pessimism has created a severe mispricing of the company's high-growth marketplace assets. AI search engines (like ChatGPT or Google Gemini) cannibalize the core TripAdvisor traffic so rapidly that the legacy business collapses before the growth assets can be spun off or fully valued.
Up Next

This Bloomberg Markets video, published March 11, 2026, features Aaron Kirchfeld, Nora, David Varley, Krishna Veeraraghavan, Jeff Smith discussing ITA, LMT, GD, NOC, PZZA, CTAS, UNF, XBI, IBB, KMX, LW, TRIP. 7 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Aaron Kirchfeld, Nora, David Varley, Krishna Veeraraghavan, Jeff Smith  · Tickers: ITA, LMT, GD, NOC, PZZA, CTAS, UNF, XBI, IBB, KMX, LW, TRIP